What is GDTC's gross margin?

CytoMed (GDTC) has a gross margin of -239% and a net margin of -1126%.

What is GDTC's P/E ratio?

Track CytoMed (GDTC) P/E ratio, ROE, and valuation metrics over time.

Where can I see GDTC's full financials?

See CytoMed (GDTC) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

CytoMed (GDTC) Financials — Revenue, Earnings, Cash Flow

$0.92

+0.02 (+2.23%)

Weekly Expected Move ±12.4%

$1 $1 $1 $1 $1

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $10.9M mcap · 3M float · 1.71% daily turnover · Short 36% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$1M

Revenue

+62.6% YoY

$-5M

Net Income

-83.6% YoY

$-6M

Free Cash Flow

-85.0% YoY

-238.9%

Gross Margin

-1272.9%

Op. Margin

-1125.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-90.6%

ROA-72.6%

ROIC-106.7%

Valuation

P/E-2.6

P/B2.8

EV/EBITDA0.0

Leverage

Debt/Equity0.09

Current Ratio2.64

Interest Cov.-187.5x

Quality Scores

Piotroski F1/9

Altman Z—

Beneish M6.45